Skip to Content

Healthpeak Properties Inc PEAK Stock Quote

| Rating as of


Morningstar‘s Stock Analysis PEAK

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Healthpeak Raises Guidance After Reporting Same-Store NOI Growth in All Three Operating Segments

Kevin Brown, CFA Senior Analyst

Analyst Note

| Kevin Brown, CFA |

Healthpeak Properties reported third-quarter results that were in line with our expectations. As a result, we are reaffirming our $36 fair value estimate for the no-moat company. Same-store cash net operating income growth was 5.4% for the life science segment, 4.9% for the medical office segment, and 4.1% for the continuing care retirement community segment. Combined, Healthpeak reported third-quarter same-store cash NOI growth of 5.1% that was slightly better than our estimate of 4.3% growth. The NOI growth across the company's operating segments led Healthpeak to report third-quarter adjusted funds from operations of $0.43 per share, in line with our estimate and 3 cents better than the $0.40 per-share figure the company reported in the third quarter of 2021.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics PEAK

Company Profile PEAK

Business Description

Healthpeak owns a diversified healthcare portfolio of approximately 462 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.

5050 South Syracuse Street, Suite 800
Denver, CO, 80237
T +1 720 428-5050
Industry REIT - Healthcare Facilities
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 196

Related News PEAK